NCT05794217View on ClinicalTrials.gov

A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

RecruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Rare Diseases
Interventions
BEHAVIORAL

This is a non-interventional study

This is a non-interventional study

Trial Locations (1)

02451

RECRUITING

Sanguine Biosciences, Waltham

Sponsors
All Listed Sponsors
lead

Sanguine Biosciences

INDUSTRY

NCT05794217 - A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives | Biotech Hunter | Biotech Hunter